FUJIFILM Biotechnologies is a global CDMO recognized for its end-to-end biologics and advanced therapy manufacturing expertise, supporting projects from preclinical development through commercial production. With facilities across the United States and Europe — including two in College Station, Texas — the company specializes in microbial, mammalian, and viral vector systems, including AAV, adenovirus, lentivirus, and poxvirus platforms. Partnering with leading biopharma innovators, FUJIFILM Biotechnologies accelerates development timelines while maintaining high-quality, cGMP-compliant production standards.
